SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-003121
Filing Date
2021-06-21
Accepted
2021-06-21 17:30:33
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 form4-06212021_050611.html 4  
1 form4-06212021_050611.xml 4 3720
  Complete submission text file 0001415889-21-003121.txt   5104
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 211032109

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations